Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Valsartan/Sacubitril for Heart Failure: Reconciling Disparities Between Preclinical and Clinical Investigations.

× No keyword cloud information.

11 in total

Review 1. Neprilysin Inhibition as a PARADIGM Shift in Heart Failure Therapy.

Authors: Ruth Hsiao; Barry Greenberg
Journal: Curr Heart Fail Rep Date: 2016-08

Review 2. Long-term neprilysin inhibition - implications for ARNIs.

Authors: Duncan J Campbell
Journal: Nat Rev Cardiol Date: 2016-12-15 Impact factor: 32.419

Review 3. Role of Angiotensin Receptor-Neprilysin Inhibition in Heart Failure.

Authors: Stuart B Prenner; Sanjiv J Shah; Clyde W Yancy
Journal: Curr Atheroscler Rep Date: 2016-08 Impact factor: 5.113

Review 4. Sacubitril/Valsartan: From Clinical Trials to Real-world Experience.

Authors: Joanna M Joly; Akshay S Desai
Journal: Curr Treat Options Cardiovasc Med Date: 2018-04-23

Review 5. Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.

Authors: Carlos M Ferrario; Adam E Mullick
Journal: Pharmacol Res Date: 2017-05-29 Impact factor: 7.658

6. Heart Failure and Cognitive Impairment in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors: Lucy S Witt; Jason Rotter; Sally C Stearns; Rebecca F Gottesman; Anna M Kucharska-Newton; A Richey Sharrett; Lisa M Wruck; Jan Bressler; Carla A Sueta; Patricia P Chang
Journal: J Gen Intern Med Date: 2018-07-20 Impact factor: 5.128

Review 7. Neprilysin inhibition: A brief review of past pharmacological strategies for heart failure treatment and future directions.

Authors: Erik H Howell; Scott J Cameron
Journal: Cardiol J Date: 2016-09-26 Impact factor: 2.737

Review 8. Sacubitril/valsartan: A novel angiotensin receptor-neprilysin inhibitor.

Authors: Ramesh R Dargad; Mahesh R Prajapati; Rohit R Dargad; Jai D Parekh
Journal: Indian Heart J Date: 2018-01-08

9. In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan.

Authors: Guillem Jorba; Joaquim Aguirre-Plans; Valentin Junet; Cristina Segú-Vergés; José Luis Ruiz; Albert Pujol; Narcís Fernández-Fuentes; José Manuel Mas; Baldo Oliva
Journal: PLoS One Date: 2020-02-13 Impact factor: 3.240

10. Sacubitril/Valsartanstive Heart Failure: Cardiogenic Shock.

Authors: H A Rawal; A G Kocheril
Journal: Case Rep Cardiol Date: 2018-05-15